Hien Liu

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma

Jennifer M. Logue, Elisa Zucchetti, Christina A. Bachmeier et al. · Haematologica · 2020 · 271 citations · Full text

Medicine, Hematology, Oncology +17

High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma

Erin Dean, Rahul Mhaskar, Hong Lü et al. · Blood Advances · 2020 · 242 citations · Full text

Medicine, Oncology, Pharmacology +17

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy

Mohamed A. Kharfan‐Dabaja, Ambuj Kumar, Ernesto Ayala et al. · Transplantation and Cellular Therapy · 2021 · 181 citations · Full text

Medicine, Hematology, Immunology +16

Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma

Austin J. Sim, Michael D. Jain, Nicholas Figura et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 162 citations

Medicine, Hematology, Oncology +14

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)

Ankit Kansagra, Noelle V. Frey, Merav Bar et al. · Bone Marrow Transplantation · 2019 · 119 citations · Full text

Medicine, Hematology, Oncology +17